• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RESONATE X4 CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RESONATE X4 CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G447
Device Problems Failure to Capture (1081); Failure to Read Input Signal (1581); Under-Sensing (1661); Low impedance (2285); High Capture Threshold (3266)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/04/2023
Event Type  malfunction  
Event Description
It was reported that this implantable pacemaker recorded an alert for left ventricular automatic threshold detected as greater than programmed amplitude or suspended due to fusion events.The left ventricular (lv) capture cannot be confirmed on the presenting electrogram (egm).It was recommended to have an assessment performed with a programmer.The lead measurements are stable, and the battery longevity status is normal.At this time, the device remains in service.No adverse patient effects were reported.
 
Event Description
It was reported that this implantable pacemaker recorded an alert for left ventricular automatic threshold detected as greater than programmed amplitude or suspended due to fusion events.The left ventricular (lv) capture cannot be confirmed on the presenting electrogram (egm).It was recommended to have an assessment performed with a programmer.The lead measurements are stable, and the battery longevity status is normal.Received additional information advising the pacemaker recorded another alert for left ventricular automatic threshold detected as greater than programmed amplitude or suspended due to fusion events.When successful the left ventricular automatic threshold test shows high threshold greater than 3v (volts) and trending shows a decrease in lv pacing impedances still within range.The electrograms (egms) show atrial fibrillation (af) with atrial undersensing observed.Atrial tachy discriminators remain programmed on.Recommended assessment of tachy programming.Received additional information advising the pacemaker recorded two previous alerts for left ventricular automatic threshold detected as greater than programmed amplitude or suspended with atrial undersensing observed.A manual lv threshold tested below programmed output.The patient was recently seen in-clinic and no programming changes were made.Received additional information the atrial intrinsic amplitude is out of range.The presenting egm continues to show undersensing of atrial arrhythmia.Programming sensitivity appears to be known and atrial intrinsic amplitude appears to be off at a clinic level.At this time, the device remains in service.No adverse patient effects were reported.
 
Event Description
It was reported that this implantable pacemaker recorded an alert for left ventricular automatic threshold detected as greater than programmed amplitude or suspended due to fusion events.The left ventricular (lv) capture cannot be confirmed on the presenting electrogram (egm).It was recommended to have an assessment performed with a programmer.The lead measurements are stable, and the battery longevity status is normal.Received additional information advising the pacemaker recorded another alert for left ventricular automatic threshold detected as greater than programmed amplitude or suspended due to fusion events.When successful the left ventricular automatic threshold test shows high threshold greater than 3v (volts) and trending shows a decrease in lv pacing impedances still within range.The electrograms (egms) show atrial fibrillation (af) with atrial undersensing observed.Atrial tachy discriminators remain programmed on.Recommended assessment of tachy programming.At this time, the device remains in service.No adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESONATE X4 CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key17656655
MDR Text Key322387962
Report Number2124215-2023-47052
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010012/S436
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date 12/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberG447
Device Catalogue NumberG447
Device Lot Number303550
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received08/30/2023
Supplement Dates Manufacturer Received09/28/2023
12/06/2023
Supplement Dates FDA Received10/24/2023
12/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/22/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age78 YR
-
-